Serum antiganglioside antibodies in patients with autoimmune limbic encephalitis

Nevertheless, potential impact of ganglioside antibodies on axonal degeneration and neuronal loss in limbic encephalitis pends to be further investigated.Key words: Ganglioside, antibody, autoimmune encephalitis, paraneoplastic, autoimmunity

📌 3 Maddede Bu Makale

🎯

Amaç & Hipotez:Background/aim: Ganglioside antibodies are identified not only in patients with inflammatory neuropathies but also several central nervous system disorders and paraneoplastic neuropathies.

📊

Temel Bulgular & Veri:Materials and methods: Sera and cerebrospinal fluid (CSF) samples of 33 patients fulfilling the criteria for probable autoimmune encephalitis were collected within the first week of clinical manifestation.

💡

Sonuç & Katkı:Nevertheless, potential impact of ganglioside antibodies on axonal degeneration and neuronal loss in limbic encephalitis pends to be further investigated.Key words: Ganglioside, antibody, autoimmune encephalitis, paraneoplastic, autoimmunity

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Ganglioside antibodies are identified not only in patients with inflammatory neuropathies but also several central nervous system disorders and paraneoplastic neuropathies. Our aim was to investigate whether ganglioside antibodies are found in autoimmune encephalitis patients and may function as a diagnostic and prognostic biomarker. Materials and methods: Sera and cerebrospinal fluid (CSF) samples of 33 patients fulfilling the criteria for probable autoimmune encephalitis were collected within the first week of clinical manifestation. None of the patients had evident symptoms and findings of peripheral polyneuropathy. Well-characterized antineuronal and paraneoplastic antibodies were investigated in sera and CSF and antiganglioside (antiGM1, GM2, GM3, GD1a, GD1b, GT1b, and GQ1b) IgG and IgM antibodies were measured in sera using commercial immunoblots. Results: Twenty-eight of 33 autoimmune encephalitis patients displayed antibodies against neuronal surface or onco-neural antigens with N-methyl-D-aspartate receptor (NMDAR), glutamic acid decarboxylase (GAD) and Hu antibodies being the most prevalent. While no antiganglioside IgG antibodies were found, 4 patients (2 anti-NMDAR+, 1 anti-GAD+ and 1 antibody negative) with autoimmune limbic encephalitis displayed anti-GM1, anti-GM2, anti-GM3 or anti-GQ1b IgM antibodies. There was no apparent association between antiganglioside positivity and clinical and demographic features. Conclusion: Serum ganglioside IgM antibodies may infrequently emerge during the clinical course of autoimmune limbic encephalitis without evident polyneuropathy. Absence of the IgG response suggests that these antibodies might have developed as a hyperacute immune response to neuro-axonal destruction. Nevertheless, potential impact of ganglioside antibodies on axonal degeneration and neuronal loss in limbic encephalitis pends to be further investigated.Key words: Ganglioside, antibody, autoimmune encephalitis, paraneoplastic, autoimmunity

🔖

Bu Makaleye Atıf Yap

ŞANLI, E., YILMAZ, V., TÜZÜN, B. B., TÜZÜN, E., KÜRTÜNCÜ, M., SELÇUK, Ö., TUNÇ, C. E., IŞILDAK, Ş., ÇOKAR, A. Ö., OKTAR, A. Ç. (2022). Serum antiganglioside antibodies in patients with autoimmune limbic encephalitis. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 5, 2570–2574. https://ajindex.com/articles/609949

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

Wanleenuwat P, Iwanowski P, Kozubski W. Antiganglioside antibodies in neurological diseases. Journal of the Neurological Sciences 2020
116576. doi: 10.1016/j.jns.2019.116576 2. Colsch B, Jackson SN, Dutta S, Woods AS. Molecular microscopy of brain gangliosides: illustrating their distribution in hippocampal cell layers. ACS Chemical Neuroscience 2011
2 (4): 213-222. doi: 10.1021/cn100096h 3. Timarova G, Lisa I, Kukumberg P. Long-term effect of rituximab in a case with late-onset Rasmussen´s encephalitis with anti-ganglioside IgGQ1b and anti-GAD antibodies positivity. Case Report. Neuro Endocrinology Letters 2016
37 (3): 179-183. 4. Çoban A, Ulusoy C, Giriş M, Turan S, Türkoğlu R et al. Serum anti-neuronal antibodies in amyotrophic lateral sclerosis. The International Journal of Neuroscience 2013
123 (8): 557-562. 5. Ding Y, Yu L, Zhou S, Zhang L. Clinical characteristic analysis of seven children with bickerstaff brainstem encephalitis in China. Frontiers in Neurology 2020
doi: 10.3389/ fneur.2020.00557 6. Merwick A, Dalmau J, Delanty N. Insights into antibodyassociated encephalitis Bickerstaff ’s 1950’s papers revisited. Journal of the Neurological Sciences 2013
334 (1-2): 167-168. doi: 10.1016/j.jns.2013.07.010 7. Kornberg AJ, Pestronk A, Blume GM, Lopate G, Yue J et al. Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes. Neurology 1996
47 (5): 1317-1320. doi: 10.1212/wnl.47.5.1317 8. Tüzün E, Kürtüncü M, Lang B, Içöz S, Akman-Demir G et al. Bickerstaff ’s encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies. European Journal of Neurology 2010
17 (10): 1304-1307. doi: 10.1111/j.1468-1331.2010.02993.x 9. De Toni L, Marconi S, Nardelli E, Alberti D, Borsellino G et al. Gangliosides act as onconeural antigens in paraneoplastic neuropathies. Journal of Neuroimmunology 2004
156 (1-2): 178-187. doi: 10.1016/j.jneuroim.2004.07.020 10. Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG et al. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology 2016
15 (4): 391-404. doi: 10.1016/S1474- 4422(15)00401-9 11. Gallagher S, Winston SE, Fuller SA, Hurrell JG. Immunoblotting and immunodetection. Current Protocols in Cell Biology 2011
6 (6.2). doi: 10.1002/0471143030.cb0602s52 12. Cutillo G, Saariaho AH, Meri S. Physiology of gangliosides and the role of antiganglioside antibodies in human dise